Fogelman AM - Search Results

1

Lipoproteins and the pathogenesis of atherosclerosis.

Steinberg D, Carew TE, Fielding C, Fogelman AM, Mahley RW, Sniderman AD, Zilversmit DB. Steinberg D, et al. Among authors: fogelman am. Circulation. 1989 Sep;80(3):719-23. doi: 10.1161/01.cir.80.3.719. Circulation. 1989. PMID: 2670321 Review. No abstract available.

2

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Berliner JA, et al. Among authors: fogelman am. Circulation. 1995 May 1;91(9):2488-96. doi: 10.1161/01.cir.91.9.2488. Circulation. 1995. PMID: 7729036 Review.

3

The complexity of high-density lipoproteins.

Fogelman AM. Fogelman AM. Circulation. 2010 Nov 9;122(19):1900-1. doi: 10.1161/CIRCULATIONAHA.110.984120. Epub 2010 Oct 25. Circulation. 2010. PMID: 20974995 No abstract available.

4

Genetic basis of atherosclerosis: part I: new genes and pathways.

Lusis AJ, Fogelman AM, Fonarow GC. Lusis AJ, et al. Among authors: fogelman am. Circulation. 2004 Sep 28;110(13):1868-73. doi: 10.1161/01.CIR.0000143041.58692.CC. Circulation. 2004. PMID: 15451808 Review. No abstract available.

5

Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice.

Navab M, Hama S, Hough G, Fogelman AM. Navab M, et al. Among authors: fogelman am. Circulation. 2003 Oct 7;108(14):1735-9. doi: 10.1161/01.CIR.0000089375.60050.35. Epub 2003 Sep 22. Circulation. 2003. PMID: 14504179

6

Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study.

Dwyer JH, Navab M, Dwyer KM, Hassan K, Sun P, Shircore A, Hama-Levy S, Hough G, Wang X, Drake T, Merz CN, Fogelman AM. Dwyer JH, et al. Among authors: fogelman am. Circulation. 2001 Jun 19;103(24):2922-7. doi: 10.1161/01.cir.103.24.2922. Circulation. 2001. PMID: 11413081

7

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.

Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, Hough G, Lallone R, Fogelman AM. Navab M, et al. Among authors: fogelman am. Circulation. 2002 Jan 22;105(3):290-2. doi: 10.1161/hc0302.103711. Circulation. 2002. PMID: 11804981

8

Genetic basis of atherosclerosis: part II: clinical implications.

Lusis AJ, Fogelman AM, Fonarow GC. Lusis AJ, et al. Among authors: fogelman am. Circulation. 2004 Oct 5;110(14):2066-71. doi: 10.1161/01.CIR.0000143098.98869.F8. Circulation. 2004. PMID: 15466657 Review. No abstract available.

9

Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.

Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Frank JS, Grijalva VR, Ganesh VK, Mishra VK, Palgunachari MN, Fogelman AM. Navab M, et al. Among authors: fogelman am. Circ Res. 2005 Sep 16;97(6):524-32. doi: 10.1161/01.RES.0000181229.69508.2f. Epub 2005 Aug 11. Circ Res. 2005. PMID: 16100046

10

Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia.

Mehrabian M, Wong J, Wang X, Jiang Z, Shi W, Fogelman AM, Lusis AJ. Mehrabian M, et al. Among authors: fogelman am. Circ Res. 2001 Jul 20;89(2):125-30. doi: 10.1161/hh1401.093458. Circ Res. 2001. PMID: 11463718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

294 results

Search Page